These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9886684)
21. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor. Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881 [TBL] [Abstract][Full Text] [Related]
22. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Hoyer D; Engel G; Kalkman HO Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410 [TBL] [Abstract][Full Text] [Related]
23. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding. Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236 [TBL] [Abstract][Full Text] [Related]
24. Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein. Zemlan FP; Schwab EF J Neurochem; 1991 Dec; 57(6):2092-9. PubMed ID: 1834802 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex. Peroutka SJ J Neurochem; 1986 Aug; 47(2):529-40. PubMed ID: 2942638 [TBL] [Abstract][Full Text] [Related]
26. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands. Barnes JM; Barnes NM; Costall B; Jagger SM; Naylor RJ; Robertson DW; Roe SY Br J Pharmacol; 1992 Feb; 105(2):500-4. PubMed ID: 1559139 [TBL] [Abstract][Full Text] [Related]
27. 5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta. Siddiqui A; Abu-Amara M; Aldairy C; Hagan JJ; Wilson C Eur J Pharmacol; 2004 Apr; 491(1):77-84. PubMed ID: 15102536 [TBL] [Abstract][Full Text] [Related]
28. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord. Manuel NA; Wallis DI; Crick H Br J Pharmacol; 1995 Nov; 116(6):2647-54. PubMed ID: 8590984 [TBL] [Abstract][Full Text] [Related]
29. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157 [TBL] [Abstract][Full Text] [Related]
30. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity. Norman AB; Battaglia G; Creese I Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462 [TBL] [Abstract][Full Text] [Related]
31. Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain. To ZP; Bonhaus DW; Eglen RM; Jakeman LB Br J Pharmacol; 1995 May; 115(1):107-16. PubMed ID: 7647964 [TBL] [Abstract][Full Text] [Related]
32. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Sleight AJ; Carolo C; Petit N; Zwingelstein C; Bourson A Mol Pharmacol; 1995 Jan; 47(1):99-103. PubMed ID: 7838138 [TBL] [Abstract][Full Text] [Related]
33. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines. Dupuis DS; Colpaert FC; Pauwels PJ Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544 [TBL] [Abstract][Full Text] [Related]
34. 5-HT1D receptors in guinea-pig and pigeon brain. Radioligand binding and biochemical studies. Waeber C; Schoeffter P; Palacios JM; Hoyer D Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):479-85. PubMed ID: 2533324 [TBL] [Abstract][Full Text] [Related]
35. Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue. Hirst WD; Minton JA; Bromidge SM; Moss SF; Latter AJ; Riley G; Routledge C; Middlemiss DN; Price GW Br J Pharmacol; 2000 Aug; 130(7):1597-605. PubMed ID: 10928963 [TBL] [Abstract][Full Text] [Related]
36. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding. Hoyer D; Neijt HC Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium. Molderings GJ; Frölich D; Likungu J; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):272-80. PubMed ID: 8692281 [TBL] [Abstract][Full Text] [Related]
38. 5-hydroxytryptamine1 recognition sites in rat brain: heterogeneity of non-5-hydroxytryptamine1A/1C binding sites revealed by quantitative receptor autoradiography. Bruinvels AT; Palacios JM; Hoyer D Neuroscience; 1993 Mar; 53(2):465-73. PubMed ID: 8492913 [TBL] [Abstract][Full Text] [Related]
39. A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain. Gustafson EL; Durkin MM; Bard JA; Zgombick J; Branchek TA Br J Pharmacol; 1996 Feb; 117(4):657-66. PubMed ID: 8646411 [TBL] [Abstract][Full Text] [Related]
40. The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum. Boess FG; Riemer C; Bös M; Bentley J; Bourson A; Sleight AJ Mol Pharmacol; 1998 Sep; 54(3):577-83. PubMed ID: 9730917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]